Histological Prognostic Factors

  • Guido Massi
  • Philip E. Leboit


In 1970 Breslow proposed a simple method for gauging melanomas according to the neoplasm’ s vertical thickness. With all its limits, this measurement remains by far the best single factor to predict the clinical behavior of a malignant melanoma.


Melanoma Cell Cutaneous Melanoma Papillary Dermis Primary Cutaneous Melanoma Superficial Spreading Melanoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark’ s and Breslow’ s staging methods. Ann Surg. 1978 Dec;188(6):732–742.PubMedCrossRefGoogle Scholar
  2. Balch CM, Wilkerson JA, Murad TM, Soong SJ, Ingalls AL, Maddox WA. The prognostic significance of ulceration of cutaneous melanoma. Cancer. 1980 Jun 15;45(12):3012–3017.PubMedCrossRefGoogle Scholar
  3. Balch CM. Cutaneous melanoma: prognosis and treatment results worlwide. Semin Surg Oncol. 1992 Nov–Dec;8(6):400–414.PubMedCrossRefGoogle Scholar
  4. Busam KJ, Antonescu CR, Marghooh AA, Nehal KS, Sachs DL, Shia J, Berwick M. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of inter oh server agreement. Am J Clin Pathol. 2001 Jun;115(6): 856–860.PubMedCrossRefGoogle Scholar
  5. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908.PubMedCrossRefGoogle Scholar
  6. Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989 Dec 20;81(24): 1893–1904.PubMedCrossRefGoogle Scholar
  7. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727.PubMedGoogle Scholar
  8. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996 Apr 1;77(7):1303–1310.PubMedCrossRefGoogle Scholar
  9. Eldh J, Boeryd B, Peterson LE. Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis. Scand J Plast Reconstr Surg. 1978;12(3):243–255.PubMedCrossRefGoogle Scholar
  10. Elder DE, Guerry D 4th, Epstein MN, Zehngebot L, Lusk E, Van Horn M, Clark WH Jr. Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol. 1984 Summer;6 Suppl:55–61.PubMedGoogle Scholar
  11. Fontaine D, Parkhill W, Greer W, Walsh N. Partial regression of primary cutaneous melanoma: is there an association with sub-clinical sentinel lymph node metastasis? Am J Dermatopathol. 2003 Oct;25(5):371–376.PubMedCrossRefGoogle Scholar
  12. Green MS, Ackerman AB. Thickness is not an accurate gauge of prognosis of primary cutaneous melanoma. Am J Dermatopathol. 1993 Oct;15(5):461–473.PubMedCrossRefGoogle Scholar
  13. Keefe M, Mackie RM. The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group. Br J Cancer. 1991 Sep;64(3):598–602.PubMedCrossRefGoogle Scholar
  14. Kelly JW, Sagebiel RW, Blois MS. Regression in malignant melanoma. A histologic feature without independent prognostic significance. Cancer. 1985 Nov 1; 56(9):2287–2291.PubMedCrossRefGoogle Scholar
  15. Kelly JW, Sagebiel RW, Clyman S, Blois MS. Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator. Ann Surg. 1985 Jul;202(1):98–103.PubMedCrossRefGoogle Scholar
  16. Lefevre M, Vergier B, Balme B, Thiebault R, Delaunay M, Thomas L, Beylot-Barry M, Machet L, De Muret A, Bioulac-Sage P, Bailly C. Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas. Am J Surg Pathol. 2003 Jun;27(6):717–724.PubMedCrossRefGoogle Scholar
  17. Pastorfide GC, Kibbi AG, de Roa AL, Barnhill RL, Sober AJ, Mihm MC Jr, Byers HR. Image analysis of stage 1 melanoma (1.00—2.50 mm): lymphocytic infiltrates related to metastasis and survival. J Cutan Pathol. 1992 Oct;19(5):390–397.PubMedCrossRefGoogle Scholar
  18. Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK. Thin malignant melanomas with regression and metastases. Arch Dermatol. 1987 Oct;123(10):1326–1330.PubMedCrossRefGoogle Scholar
  19. Ronan SG, Han MC, Das Gupta TK. Histologic prognostic indicators in cutaneous malignant melanoma. Semin Oncol 1988 Dec;15(6):558–565.PubMedGoogle Scholar
  20. Scolyer RA, Shaw HM, Thompson JF, Li LX, Colman MH, Lo SK, McCarthy SW, Palmer AA, Nicoll KD, Dutta B, Slobedman E, Watson GF, Stretch JR. Inter observer reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol. 2003 Dec;27(12):1571–1576.PubMedCrossRefGoogle Scholar
  21. Schmoeckel C, Braun-Falco O. Prognostic index in malignant melanoma. Arch Dermatol. 1978 Jun;114(6):871–873.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Guido Massi
    • 1
  • Philip E. Leboit
    • 2
  1. 1.Department of PathologyCatholic University Medical SchoolRomeItaly
  2. 2.University of CaliforniaSan FranciscoUSA

Personalised recommendations